Core Viewpoint - Meinian Health's stock price has shown significant growth this year, with a year-to-date increase of 34.37% and a recent surge of 25.77% over the past five trading days, indicating strong market interest and performance [1]. Financial Performance - For the period from January to September 2025, Meinian Health reported a revenue of 6.925 billion yuan, reflecting a year-on-year decrease of 3.01%. However, the net profit attributable to shareholders was 51.86 million yuan, which represents a substantial year-on-year increase of 110.53% [2]. Stock Market Activity - As of December 19, Meinian Health's stock price reached 6.15 yuan per share, with a trading volume of 2.34 billion yuan and a turnover rate of 9.85%. The total market capitalization stands at 24.073 billion yuan [1]. - The company has appeared on the "龙虎榜" (a list of stocks with significant trading activity) three times this year, with the most recent appearance on December 18, where it recorded a net buying of 171 million yuan [1]. Shareholder Information - As of September 30, 2025, Meinian Health had 152,000 shareholders, a decrease of 11.85% from the previous period. The average number of circulating shares per person increased by 13.44% to 25,490 shares [2]. - The top ten circulating shareholders include notable ETFs, with Huabao Zhongzheng Medical ETF holding 88.664 million shares, a decrease of 15.1218 million shares from the previous period [3].
美年健康涨2.16%,成交额23.40亿元,主力资金净流出4.13亿元